Roche un­veils long-term da­ta from piv­otal spinal mus­cu­lar at­ro­phy tri­al

Bio­gen and No­var­tis have pre­vi­ous­ly rolled out long-term da­ta with their re­spec­tive spinal mus­cu­lar at­ro­phy ther­a­pies Spin­raza and Zol­gens­ma. Now, Roche is seek­ing to catch …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER